370 analyzer

The anthropometric assessment comprised body height, body weight, and waist circumferences. During the morning measurements, women were fasting and were barefoot wearing light clothing. Body weight and height were measured by a calibrated electronic scale with a stadiometer (model WPT 100/200 OW from RadWag, Radom, Poland). Waist circumference was determined at the horizontal plane, midway between the lowest rib and iliac crest using a standard measuring tape (Seca, Hamburg, Germany). Based on the anthropometric measurement, BMI was calculated by dividing body weight (kg) by the square of body height (m²). In this study, obesity was recognized according to the World Health Organization criteria [37 ]. Waist circumference was categorized according to cut-off points defined by the International Diabetes Federation [38 ]. Additionally, body composition was assessed during the recruitment process using the bioimpedance analysis with the InBody 370 analyzer (InBody Co. Ltd., Seoul, South Korea). Body composition was evaluated to check if participants fulfill the inclusion criteria. We used 32% of body fat as a criterium for diagnosing obesity in women, which is in line with the American Council on Exercise recommendation [34 ].

Before the study intervention, several anthropometric parameters, including body weight, height, and waist circumference, were collected. Moreover, BMI was calculated. During the measurements, the participants wore no shoes and minimal clothes. Moreover, an assessment of body composition was performed during the recruitment process to check if subjects fulfilled the inclusion criteria (body fat ≥32%). Body composition was assessed using the bioimpedance method with the InBody 370 analyzer (InBody Co. Ltd., Seoul, Korea).